S. Rebello

发表

Comparison of Men and Women With Axial Spondyloarthritis in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry

A. Ogdie, P. Mease, Yujin Park, 2021, The Journal of Rheumatology.

Characterization of Patients With Axial Spondyloarthritis by Enthesitis Presence: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

A. Ogdie, P. Mease, Yujin Park, 2020, ACR open rheumatology.

Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA

L. Harrold, V. Khaychuk, S. Kelly, 2021, Rheumatology and Therapy.

Association of Nail Psoriasis With Disease Activity Measures and Impact in Psoriatic Arthritis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

A. Ogdie, P. Mease, R. McLean, 2020, The Journal of Rheumatology.

Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis

J. Kremer, L. Harrold, E. Alemao, 2020, Current medical research and opinion.

Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study

J. Kremer, L. Harrold, H. Litman, 2018, The Journal of Rheumatology.

Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data

D. Pappas, G. Kricorian, N. Accortt, 2020, Rheumatology International.

Therapy with Biologic Agents After Diagnosis of Solid Malignancies: Results from the Corrona Registry

D. Pappas, D. Collier, N. Accortt, 2019, The Journal of Rheumatology.

Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA

J. Kremer, D. Pappas, L. Harrold, 2021, Rheumatology and Therapy.

A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?

J. Kremer, L. Harrold, H. Litman, 2017, Clinical Rheumatology.

Effect of Multidomain Disease Presentations on Patients With Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

A. Ogdie, P. Mease, R. McLean, 2020, The Journal of Rheumatology.

Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity

J. Greenberg, L. Harrold, D. Collier, 2018, The Journal of Rheumatology.

Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry

J. Greenberg, L. Harrold, D. Collier, 2017, Clinical Rheumatology.

Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience From the Corrona PsA/SpA Registry

A. Armstrong, J. Greenberg, P. Mease, 2020, The Journal of Rheumatology.

THU0397 CLINICAL CHARACTERISTICS AND TREATMENT PROFILES OF PATIENTS WITH ANKYLOSING SPONDYLITIS WHO INITIATED SECUKINUMAB AND OTHER BIOLOGICS: RESULTS FROM THE CORRONA PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS (PSA/SPA) REGISTRY

A. Ogdie, P. Mease, Yujin Park, 2019, Poster Presentations.

Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting

J. Greenberg, P. Mease, D. Collier, 2019, Rheumatology International.

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis

J. Curtis, N. Accortt, Youfu Li, 2018, Arthritis care & research.

Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry

A. Armstrong, J. Greenberg, P. Mease, 2019, RMD Open.

Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries

J. Greenberg, P. Mease, Hyung-Min Kang, 2019, Rheumatology and Therapy.

Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real-world Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry

A. Ogdie, P. Mease, R. McLean, 2020, The Journal of Rheumatology.

Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study

A. Araujo, L. Harrold, G. Reed, 2018, Rheumatology and Therapy.

Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry

J. Kremer, L. Harrold, H. Litman, 2018, The Journal of Rheumatology.

Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry

D. Pappas, G. Kricorian, N. Accortt, 2020, ACR open rheumatology.

Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry

P. Mease, D. Collier, M. Gharaibeh, 2021, Arthritis Research & Therapy.

SAT0388 CHARACTERIZATION OF PATIENTS WITH PSORIATIC ARTHRITIS AND NAIL PSORIASIS: DATA FROM THE CORRONA PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS (PSA/SPA) REGISTRY

A. Ogdie, P. Mease, R. McLean, 2019, Saturday, 15 June 2019.

Prevalence of Sjögren’s syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry

J. Kremer, L. Harrold, E. Rosenstein, 2020, Clinical Rheumatology.

OP0178 Impact of Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor Status on Response To Abatacept Therapy: Findings from A US Observational Cohort

L. Harrold, H. Litman, E. Alemao, 2016 .

FRI0205 Relationship between Anti-Citrullinated Protein Antibody Status and Response To Abatacept or Anti-Tumour Necrosis Factor Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study

L. Harrold, H. Litman, E. Alemao, 2016 .

Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry

J. Kremer, L. Harrold, H. Litman, 2019, Rheumatology and Therapy.

The Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire: Development of a Conceptual Model and Disease-Specific Patient-Reported Outcome Measure

I. Lousada, L. Broderick, S. Rebello, 2023, Patient related outcome measures.

Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light‐chain amyloidosis

P. Hawkins, A. Wechalekar, H. Lachmann, 2023, British journal of haematology.

Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry

A. Armstrong, J. Greenberg, P. Mease, 2019, RMD Open.

Increased healthcare resource utilization in higher disease activity levels in initiators of TNF inhibitors among US rheumatoid arthritis patients

M. Mason, A. Araujo, L. Harrold, 2016, Current medical research and opinion.